Central anticholinergic syndrome following dobutamine-atropine stress echocardiography

Michael Wilson, Glenn K. Lee, Anupam Chandra, Garvan M Kane

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

We present a case of central anticholinergic syndrome following dobutamine-atropine stress echocardiography in an elderly female. Although atropine toxicity is a recognized complication of stress echocardiography, no case reports are currently available. The central nervous system side effects of atropine are varied in severity (mild cognitive impairment to severe coma) and spectrum (agitation or somnolence), and thus are often overlooked. Management includes prompt recognition, stopping the offending agent, providing supportive care, and consideration of physiostigmine. Atropine is used in up to 60% of dobutamine stress echocardiograms, and has the potential to cause morbidity.

Original languageEnglish (US)
JournalEchocardiography
Volume28
Issue number10
DOIs
StatePublished - Nov 2011

Fingerprint

Anticholinergic Syndrome
Stress Echocardiography
Atropine
Dobutamine
Coma
Central Nervous System
Morbidity

Keywords

  • atropine
  • dobutamine stress echocardiography

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Radiology Nuclear Medicine and imaging

Cite this

Central anticholinergic syndrome following dobutamine-atropine stress echocardiography. / Wilson, Michael; Lee, Glenn K.; Chandra, Anupam; Kane, Garvan M.

In: Echocardiography, Vol. 28, No. 10, 11.2011.

Research output: Contribution to journalArticle

@article{31f0f33dd1e7460c944eb6fc17634133,
title = "Central anticholinergic syndrome following dobutamine-atropine stress echocardiography",
abstract = "We present a case of central anticholinergic syndrome following dobutamine-atropine stress echocardiography in an elderly female. Although atropine toxicity is a recognized complication of stress echocardiography, no case reports are currently available. The central nervous system side effects of atropine are varied in severity (mild cognitive impairment to severe coma) and spectrum (agitation or somnolence), and thus are often overlooked. Management includes prompt recognition, stopping the offending agent, providing supportive care, and consideration of physiostigmine. Atropine is used in up to 60{\%} of dobutamine stress echocardiograms, and has the potential to cause morbidity.",
keywords = "atropine, dobutamine stress echocardiography",
author = "Michael Wilson and Lee, {Glenn K.} and Anupam Chandra and Kane, {Garvan M}",
year = "2011",
month = "11",
doi = "10.1111/j.1540-8175.2011.01509.x",
language = "English (US)",
volume = "28",
journal = "Echocardiography",
issn = "0742-2822",
publisher = "Wiley-Blackwell",
number = "10",

}

TY - JOUR

T1 - Central anticholinergic syndrome following dobutamine-atropine stress echocardiography

AU - Wilson, Michael

AU - Lee, Glenn K.

AU - Chandra, Anupam

AU - Kane, Garvan M

PY - 2011/11

Y1 - 2011/11

N2 - We present a case of central anticholinergic syndrome following dobutamine-atropine stress echocardiography in an elderly female. Although atropine toxicity is a recognized complication of stress echocardiography, no case reports are currently available. The central nervous system side effects of atropine are varied in severity (mild cognitive impairment to severe coma) and spectrum (agitation or somnolence), and thus are often overlooked. Management includes prompt recognition, stopping the offending agent, providing supportive care, and consideration of physiostigmine. Atropine is used in up to 60% of dobutamine stress echocardiograms, and has the potential to cause morbidity.

AB - We present a case of central anticholinergic syndrome following dobutamine-atropine stress echocardiography in an elderly female. Although atropine toxicity is a recognized complication of stress echocardiography, no case reports are currently available. The central nervous system side effects of atropine are varied in severity (mild cognitive impairment to severe coma) and spectrum (agitation or somnolence), and thus are often overlooked. Management includes prompt recognition, stopping the offending agent, providing supportive care, and consideration of physiostigmine. Atropine is used in up to 60% of dobutamine stress echocardiograms, and has the potential to cause morbidity.

KW - atropine

KW - dobutamine stress echocardiography

UR - http://www.scopus.com/inward/record.url?scp=81155148162&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=81155148162&partnerID=8YFLogxK

U2 - 10.1111/j.1540-8175.2011.01509.x

DO - 10.1111/j.1540-8175.2011.01509.x

M3 - Article

C2 - 21929583

AN - SCOPUS:81155148162

VL - 28

JO - Echocardiography

JF - Echocardiography

SN - 0742-2822

IS - 10

ER -